Thevkar Nagesh P, Cho Y, Zhuang Y, Babuta M, Ortega-Ribera M, Joshi R
Sci Transl Med. 2024; 16(759):eadg1915.
PMID: 39110779
PMC: 11831603.
DOI: 10.1126/scitranslmed.adg1915.
Hedin W, Bergman P, Akhirunessa M, Soderholm S, Buggert M, Granberg T
J Clin Immunol. 2024; 44(5):116.
PMID: 38676861
PMC: 11055791.
DOI: 10.1007/s10875-024-01718-5.
Chear C, Ismail I, Chan K, Mohd Noh L, Kassim A, Abdul Latiff A
Front Immunol. 2023; 14:1252765.
PMID: 37809070
PMC: 10560089.
DOI: 10.3389/fimmu.2023.1252765.
Le Huray K, Wang H, Sobott F, Kalli A
Sci Adv. 2022; 8(27):eabn6992.
PMID: 35857458
PMC: 9258823.
DOI: 10.1126/sciadv.abn6992.
De Novellis D, Cacace F, Caprioli V, Wierda W, Mahadeo K, Tambaro F
Pharmaceutics. 2021; 13(12).
PMID: 34959482
PMC: 8709313.
DOI: 10.3390/pharmaceutics13122201.
Evaluation of the Pharmacokinetics and Safety of a Single Dose of Acalabrutinib in Subjects With Hepatic Impairment.
Xu Y, Izumi R, Nguyen H, Kwan A, Kuo H, Madere J
J Clin Pharmacol. 2021; 62(6):812-822.
PMID: 34897701
PMC: 9303693.
DOI: 10.1002/jcph.2013.
Safety and antitumor activity of acalabrutinib for relapsed/refractory B-cell malignancies: A Japanese phase I study.
Izutsu K, Ando K, Ennishi D, Shibayama H, Suzumiya J, Yamamoto K
Cancer Sci. 2021; 112(6):2405-2415.
PMID: 33728735
PMC: 8177795.
DOI: 10.1111/cas.14886.
In silico immune infiltration profiling combined with functional enrichment analysis reveals a potential role for naïve B cells as a trigger for severe immune responses in the lungs of COVID-19 patients.
Wu Y, Wang S, Wu C, Yen L, Lai H, Ho C
PLoS One. 2020; 15(12):e0242900.
PMID: 33264345
PMC: 7710067.
DOI: 10.1371/journal.pone.0242900.
Btk SH2-kinase interface is critical for allosteric kinase activation and its targeting inhibits B-cell neoplasms.
Duarte D, Lamontanara A, La Sala G, Jeong S, Sohn Y, Panjkovich A
Nat Commun. 2020; 11(1):2319.
PMID: 32385234
PMC: 7210950.
DOI: 10.1038/s41467-020-16128-5.
Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover.
Soresina A, Moratto D, Chiarini M, Paolillo C, Baresi G, Foca E
Pediatr Allergy Immunol. 2020; 31(5):565-569.
PMID: 32319118
PMC: 7264678.
DOI: 10.1111/pai.13263.
Distinct pathways regulate Syk protein activation downstream of immune tyrosine activation motif (ITAM) and hemITAM receptors in platelets.
Manne B, Badolia R, Dangelmaier C, Eble J, Ellmeier W, Kahn M
J Biol Chem. 2015; 290(18):11557-68.
PMID: 25767114
PMC: 4416859.
DOI: 10.1074/jbc.M114.629527.
A novel Bruton's tyrosine kinase gene (BTK) missense mutation in a Chinese family with X-linked agammaglobulinemia.
Zheng B, Zhang Y, Jin Y, Yu H
BMC Pediatr. 2014; 14:265.
PMID: 25316352
PMC: 4286934.
DOI: 10.1186/1471-2431-14-265.
Bruton's tyrosine kinase: from X-linked agammaglobulinemia toward targeted therapy for B-cell malignancies.
Ponader S, Burger J
J Clin Oncol. 2014; 32(17):1830-9.
PMID: 24778403
PMC: 5073382.
DOI: 10.1200/JCO.2013.53.1046.
Absence of Tec family kinases interleukin-2 inducible T cell kinase (Itk) and Bruton's tyrosine kinase (Btk) severely impairs Fc epsilonRI-dependent mast cell responses.
Iyer A, Morales J, Huang W, Ojo F, Ning G, Wills E
J Biol Chem. 2011; 286(11):9503-13.
PMID: 21212279
PMC: 3059023.
DOI: 10.1074/jbc.M110.165613.
Identification of an allosteric signaling network within Tec family kinases.
Joseph R, Xie Q, Andreotti A
J Mol Biol. 2010; 403(2):231-42.
PMID: 20826165
PMC: 2949508.
DOI: 10.1016/j.jmb.2010.08.035.
SH2-dependent autophosphorylation within the Tec family kinase Itk.
Joseph R, Severin A, Min L, Fulton D, Andreotti A
J Mol Biol. 2009; 391(1):164-77.
PMID: 19523959
PMC: 2722949.
DOI: 10.1016/j.jmb.2009.06.023.
Conformational snapshots of Tec kinases during signaling.
Joseph R, Andreotti A
Immunol Rev. 2009; 228(1):74-92.
PMID: 19290922
PMC: 2669291.
DOI: 10.1111/j.1600-065X.2008.00740.x.
The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib.
Hantschel O, Rix U, Schmidt U, Burckstummer T, Kneidinger M, Schutze G
Proc Natl Acad Sci U S A. 2007; 104(33):13283-8.
PMID: 17684099
PMC: 1940229.
DOI: 10.1073/pnas.0702654104.
Genetic approaches to tyrosine kinase signaling pathways in the immune system.
Schwartzberg P
Immunol Res. 2003; 27(2-3):481-8.
PMID: 12857991
DOI: 10.1385/IR:27:2-3:481.
Phosphoinositide 3-kinase and Bruton's tyrosine kinase regulate overlapping sets of genes in B lymphocytes.
Fruman D, Ferl G, An S, Donahue A, Satterthwaite A, Witte O
Proc Natl Acad Sci U S A. 2002; 99(1):359-64.
PMID: 11756681
PMC: 117565.
DOI: 10.1073/pnas.012605099.